Related Experiment Videos

[Follow-up control of ultrasonographic neonatal screening of the hip]

B Schüle1, H Wissel, W Neumann

  • 1Orthopädische Klinik und Poliklinik Heinrich-Heine-Universität Düsseldorf.

Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|October 16, 1999
PubMed

Insights

Early ultrasound screening for congenital hip dislocation (CDH) in newborns is crucial. Prompt treatment ensures normal hip development, with 97% of screened infants showing normal hip joints by four months.

Area of Science:

  • Pediatrics
  • Orthopedic Surgery
  • Diagnostic Imaging

Background:

  • Congenital hip dislocation (CDH) is a significant pediatric condition.
  • Early diagnosis and intervention are critical for optimal outcomes.
  • Ultrasound is a valuable tool for neonatal screening.

Purpose of the Study:

  • To evaluate the efficacy of a general ultrasound screening program for early CDH diagnosis.
  • To assess the treatment outcomes for diagnosed cases of hip dysplasia or dislocation.
  • To determine the incidence of developmental dysplasia of the hip (DDH) requiring treatment in newborns.

Main Methods:

  • A screening program involving ultrasound examination of 1656 newborns.
  • Application of Graf's classification for hip joint assessment.
  • Follow-up evaluation of hip joint development after treatment.

Main Results:

  • 2.5% of newborns were diagnosed with hip dysplasia or dislocation requiring treatment.
  • All treated cases achieved normal hip joint development.
  • 11.3% of type IIa hips evolved to type IIb (Graf classification) by 12 weeks.
  • 97% of all screened hip joints were normal by 4 months of age.

Conclusions:

  • A universal ultrasound screening program for CDH is necessary.
  • Early and appropriate treatment of CDH leads to normal hip development.
  • Ultrasound screening effectively identifies infants requiring intervention for hip abnormalities.

Related Concept Videos